Table 2. Stage Tis, Ta Risk-Matched Tumor Bank Cohort – 80 Patients.
Characteristic | Progression (n = 16) N (%) | No Progression (n = 64) N (%) | P-Value |
---|---|---|---|
Median Age (IQR) | 74 (60-78) | 69 (62-78) | 0.66 |
Male | 16 (100) | 63 (98) | 1.00 |
High Grade* | 9 (56) | 37 (58) | 0.91 |
CIS+ | 9 (56) | 27 (42) | 0.31 |
Multifocal | 10 (63) | 19 (30) | 0.01 |
> 3 cm | 3 (19) | 10 (16) | 0.76 |
EORTC High-Risk Group** | 9 (56) | 37 (58) | 0.91 |
Prior Local Treatment | 1 (6) | 5 (8) | 1.00 |
Median Follow-up in Years (IQR) | 6.6 (4.6-10.7) | 5.5 (3.5-8.4) | 0.32 |
2004 World Health Organization grade definitions
European Organisation for Research and Treatment of Cancer